ACM
LRMR icon

ADAR1 Capital Management’s Larimar Therapeutics LRMR Stock Holding History

ADAR1 Capital Management’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$832K Buy
272,745
+220,000
+417% +$874K 0.04% 181
2026
Q1 		$237K Sell
52,745
-132,944
-72% -$531K 0.01% 254
2025
Q4 		$707K Sell
185,689
-50,000
-21% -$194K 0.05% 165
2025
Q3 		$761K Sell
235,689
-1,916
-0.8% -$7.18K 0.07% 112
2025
Q2 		$687K Buy
+237,605
New +$550K 0.11% 100

Other funds holding LRMR

Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

ADAR1 Capital Management's LRMR Position: Q2 2026 in Review

ADAR1 Capital Management increased its Larimar Therapeutics (LRMR) stake by 417% in Q2 2026, buying an estimated $874K and bringing the position to 272,745 shares worth $832K. The position accounts for 0.04% of the portfolio, ranked #181.

ADAR1 Capital Management first reported a position in LRMR in Q2 2025 and has held it in 5 quarters since. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • ADAR1 Capital Management held 272,745 shares of Larimar Therapeutics worth $832K as of Q2 2026.
  • ADAR1 Capital Management bought 220,000 Larimar Therapeutics shares in Q2 2026, an estimated $874K.
  • Larimar Therapeutics made up 0.04% of ADAR1 Capital Management's portfolio in Q2 2026, its #181 holding.
  • ADAR1 Capital Management first reported a position in Larimar Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.